This inventor holds 2 USPTO granted patents. Top assignee: Transgene S.a.. Active years: 2000-2006.
Company Filing History:
Years Active: 2000-2006
Title: Cécile Chartier: Innovator in Viral Vector Technology
Introduction
Cécile Chartier is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of viral vector technology, particularly in the context of gene therapy. With a total of 2 patents, her work has the potential to impact therapeutic approaches in medicine.
Latest Patents
Cécile Chartier's latest patents include a method for the preparation of a viral vector by intermolecular homologous recombination. This invention encompasses methods of preparing a recombinant viral vector within a prokaryotic cell, utilizing intermolecular homologous recombination. Additionally, it details methods for preparing an infectious viral particle containing the recombinant viral vector and pharmaceutical compositions comprising said vector or particle. The invention also highlights the therapeutic use of the vector or particle, especially in human gene therapy.
Career Highlights
Cécile Chartier is currently associated with Transgene S.A., a company known for its innovative approaches in biotechnology. Her work at Transgene S.A. has allowed her to explore and develop advanced methodologies in the preparation of viral vectors.
Collaborations
Cécile collaborates with Eric Degryse, contributing to the advancement of their shared research interests in viral vector technology.
Conclusion
Cécile Chartier's innovative work in viral vector technology positions her as a key figure in the field of gene therapy. Her patents reflect her commitment to advancing medical science and improving therapeutic options for patients.